2014 Annual Meeting | 7FC.003 - Cerebrovascular Disease

Date Friday 05/02/14

Time 09:00 AM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) Cheryl Bushnell, MD, MHS

Topic(s)

Learning Objectives Participants should be familiar with the latest recommendations and controversies regarding the evaluation and management of patients with all stroke types, including acute ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage; be able to initiate optimal secondary prevention strategies after ischemic stroke, including selection of the optimal antithrombotic agent using the most recently published data and appropriate aggressive risk factor management; be able to manage intracranial and extracranial large artery occlusive disease, selecting the best surgical or endovascular option; and be able to recognize differences in risk factors and stroke etiologies in young adults, including pregnancy.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic, Interactive

Event Timeline
09:00 AM - 09:45 AM		Contemporary Management of Acute Ischemic Stroke Shyam Prabhakaran, MD
09:45 AM - 09:50 AM		Questions and Answers Shyam Prabhakaran, MD
09:50 AM - 10:35 AM		Contemporary Management of Intracranial and Extracranial Large Vessel Disease Seemant Chaturvedi, MD, FAHA, FAAN
10:35 AM - 10:40 AM		Questions and Answers Seemant Chaturvedi, MD, FAHA, FAAN
10:40 AM - 10:55 AM		Break
10:55 AM - 11:40 AM		The Spectrum of Stroke in Young Adults: Diagnosis and Management Cheryl Bushnell, MD, MHS
11:40 AM - 11:45 AM		Questions and Answers Cheryl Bushnell, MD, MHS
11:45 AM - 12:45 PM		Lunch
12:45 PM - 01:30 PM		Stroke Prevention in Atrial Fibrillation Moira Kapral, MD
01:30 PM - 01:35 PM		Questions and Answers Moira Kapral, MD
01:35 PM - 02:20 PM		Update on Recurrent Stroke Prevention: Guidelines and New Evidence That May Influence Practice Philip B. Gorelick, MD, MPH, FAAN
02:20 PM - 02:30 PM		Questions and Answers Philip B. Gorelick, MD, MPH, FAAN
02:30 PM - 02:45 PM		Break
02:45 PM - 03:30 PM		Contemporary Management of Intracerebral Hemorrhage Kazuma Nakagawa, MD, FAAN
03:30 PM - 03:40 PM		Questions and Answers Kazuma Nakagawa, MD, FAAN
03:40 PM - 04:25 PM		Contemporary Management of Subarachnoid Hemorrhage Vineeta Singh, MD, FAAN
04:25 PM - 04:30 PM		Questions and Answers Vineeta Singh, MD, FAAN
04:30 PM - 05:00 PM		Discussion

Faculty Disclosures
Cheryl Bushnell, MD, MHS	The institution of Dr. Bushnell has received research support from PCORI. The institution of Dr. Bushnell has received research support from NIH/NINDS. Dr. Bushnell has received intellectual property interests from a discovery or technology relating to health care. Dr. Bushnell has received publishing royalties from a publication relating to health care.
Seemant Chaturvedi, MD, FAHA, FAAN	Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Chaturvedi has received research support from NINDS.
Shyam Prabhakaran, MD	Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. The institution of Dr. Prabhakaran has received research support from NIH . The institution of Dr. Prabhakaran has received research support from AHRQ. Dr. Prabhakaran has received publishing royalties from a publication relating to health care.
Moira Kapral, MD	The institution of Moira Kapral, MD has received research support from Heart and Stroke Foundation of Canada, Canadian Institutes of Health Research.
Philip B. Gorelick, MD, MPH, FAAN	Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Thorek Memorial Hospital. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Thorek Memorial Hospital.
Vineeta Singh, MD, FAAN	Dr. Singh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genae Americas, Inc. .
Kazuma Nakagawa, MD, FAAN	Dr. Nakagawa has nothing to disclose.

��ɫ��

��ɫ��